(-)-Flurbiprofen
-
(-)-Flurbiprofen
structure -
-
CAS No:
51543-40-9
-
Formula:
C15H13FO2
-
Chemical Name:
(-)-Flurbiprofen
-
Synonyms:
[1,1′-Biphenyl]-4-acetic acid,2-fluoro-α-methyl-,(αR)-;[1,1′-Biphenyl]-4-acetic acid,2-fluoro-α-methyl-,(R)-;(αR)-2-Fluoro-α-methyl[1,1′-biphenyl]-4-acetic acid;(-)-Flurbiprofen;l-Flurbiprofen;R-(-)-Flurbiprofen;(-)-(R)-Flurbiprofen;(R)-Flurbiprofen;E 7869;MPC 7869;Tarenflurbil;Flurizan;(R)-(-)-2-(2-Fluorobiphenyl-4-yl)propionic acid;(R)-Flurbiprofen;(2R)-2-(3-Fluoro-4-phenylphenyl)propanoic acid
- Categories:
-
CAS No:
Description
Tarenflurbil ((R)-Flurbiprofen) is the R-enantiomer of the racemate NSAID Flurbiprofen, Tarenflurbil ((R)-Flurbiprofen) inhibits the binding of [3H]9-cis-RA to RXRα LBD with IC50 of 75 μM.
(R)-flurbiprofen is a flurbiprofen. It is an enantiomer of a (S)-flurbiprofen.|Tarenflurbil is an investigational drug that was studied in patients with mild Alzheimer's disease. It is a selective amyloid lowering agent (SALA) that reduces levels of the toxic peptide amyloid beta 42 (Aβ42) in cultured human cells and in animal models. Aβ42 is the primary initiator of neurotoxicity and amyloid plaque development in the brains of Alzheimer's disease patients. In June 2008 development of the drug for Alzheimer's disease was discontinued. Tarenflurbil has also been used in trials studying the treatment of Prostate Cancer.|Tarenflurbil is an orally active synthetic enantiomer of flurbiprofen. Tarenflurbil activates c-Jun N terminal kinase, increases AP-1 binding to DNA, and downregulates cyclin D1 expression, resulting in arrest of tumor cells in the G1 phase of the cell cycle and apoptosis. This agent also affects the expression of nuclear factor kappa B, a rapid response transcription factor that stimulates the immune response to tumor cells. R-flurbiprofen does not inhibit the enzyme cyclo-oxygenase.
(-)-Flurbiprofen Basic Attributes
244.26100
244.26
257-264-7
501W00OOWA
685699
DTXSID40199508
C26666
2916399090
Safety Information
UN 2811
3
R25
S26-S36/37/39-S45
T
P301 + P310
H301
|Danger|H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]|P264, P270, P301+P310, P321, P330, P405, and P501|Aggregated GHS information provided by 128 companies from 2 notifications to the ECHA C&L Inventory.
Drug Information
Investigated for use/treatment in alzheimer's disease and prostate cancer.
Flurbiprofen has known human metabolites that include (2S,3S,4S,5R)-6-[(2R)-2-(3-fluoro-4-phenylphenyl)propanoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid.
MPC-7869 is not an inhibitor of cyclooxygenase enzymes (COX-1 and COX-2). The compound modulates the signal transduction and transcription activation pathways associated with nuclear factor kappaB (NFkappaB), a principle transcription factor in the expression of many molecules involved in cell growth, cell death and inflammation. In addition, MPC-7869 has recently been shown to modulate gamma-secretase and selectively lower levels of Abeta42 peptide in vitro and in vivo, and to reduce amyloid pathology in the brain. MPC-7869 has an excellent safety profile and is very potent in animal models of cancer and Alzheimer's disease. In transgenic mouse studies, MPC-7869 reduced brain amyloid levels and prevented memory loss.
flurizan
(-)-Flurbiprofen Use and Manufacturing
(R)-2-Flurbiprofen is the R-isomer of Flurbiprofen (F598700), an anti-inflammatory used as an analgesic.
Computed Properties
Molecular Weight:244.26
XLogP3:4.2
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:3
Exact Mass:244.08995782
Monoisotopic Mass:244.08995782
Topological Polar Surface Area:37.3
Heavy Atom Count:18
Complexity:286
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of (-)-Flurbiprofen
-
CN
2 YRS
Business licensed Certified factoryManufactory Supplier of Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2,GPC,supplements -
CN
1 YR
Business licensedTrader Supplier of pregabalin,Tirzepatide,Retatrutide,Food Additives,semaglutide,Cosmetics material,Food additive,Chemical intermediate,Active pharmaceutical ingredientsInquiryUnit Price: $10 /KG FOBCAS No.: 51543-40-9Grade: USP / EP / BP / JP GradeContent: 99%
Learn More Other Chemicals
-
2,4-Dichloro-3-methylpyridine
132097-09-7
-
2,6-Dibromo-3-fluoropyridine
41404-59-5
-
Triphenylacetic acid
595-91-5
-
3-Chloro-5-fluoro-4-pyridinecarboxylic acid Formula
514798-03-9
-
2-CHLORO-4-PHENYLPYRIDINE Formula
42260-39-9
-
2-Phenyl-4-quinolinecarboxylic acid Formula
132-60-5
-
Naproxen sodium Structure
26159-34-2
-
Glycine, N,N-diethyl-, 4-(acetylamino)phenyl ester, hydrochloride (1:1) Structure
66532-86-3
-
What is 2-[(3-Chlorophenyl)amino]benzoic acid
13278-36-9
-
What is Cinaproxen
89163-44-0